118 related articles for article (PubMed ID: 38376425)
1. Statement of Retraction: The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells.
Bioengineered; 2024 Dec; 15(1):2299572. PubMed ID: 38376425
[No Abstract] [Full Text] [Related]
2. The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells.
Zhang J; Xu X; Chen Y; Guan X; Zhu H; Qi Y
Bioengineered; 2022 Jan; 13(1):624-633. PubMed ID: 34898375
[TBL] [Abstract][Full Text] [Related]
3. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C
Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389
[TBL] [Abstract][Full Text] [Related]
4. The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.
Knauer SK; Bier C; Habtemichael N; Stauber RH
EMBO Rep; 2006 Dec; 7(12):1259-65. PubMed ID: 17099693
[TBL] [Abstract][Full Text] [Related]
5. FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5.
Huang Y; Jin H; Liu Y; Zhou J; Ding J; Cheng KW; Yu Y; Feng Y
Endocr Relat Cancer; 2011 Feb; 18(1):13-26. PubMed ID: 20943720
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer.
Wang Y; Wang Y; Xiang J; Ji F; Deng Y; Tang C; Yang S; Xi Q; Liu R; Di W
Cancer Lett; 2014 Feb; 343(1):6-13. PubMed ID: 24018641
[TBL] [Abstract][Full Text] [Related]
7. CRM1 and chromosomal passenger complex component survivin are essential to normal mitosis progress and to preserve keratinocytes from mitotic abnormalities.
Labarrade F; Botto JM; Domloge N
Int J Cosmet Sci; 2016 Oct; 38(5):452-61. PubMed ID: 26859314
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways.
Pathria G; Wagner C; Wagner SN
J Invest Dermatol; 2012 Dec; 132(12):2780-90. PubMed ID: 22832492
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy.
Gao W; Lu C; Chen L; Keohavong P
J Thorac Oncol; 2015 May; 10(5):815-825. PubMed ID: 25629636
[TBL] [Abstract][Full Text] [Related]
10. Domatinostat Targets the FOXM1-Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents.
Nakagawa-Saito Y; Mitobe Y; Suzuki S; Togashi K; Sugai A; Kitanaka C; Okada M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445993
[TBL] [Abstract][Full Text] [Related]
11. [Effects of survivin antisense oligonucleotides on survivin and Smac gene expression in ovarian cancer cells].
Sun Y; Li Y; Fan LQ; Wu XH; Cheng JX; Zhao Q
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1571-4. PubMed ID: 17959540
[TBL] [Abstract][Full Text] [Related]
12. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
Wang DY; Li N; Cui YL
Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
[TBL] [Abstract][Full Text] [Related]
13. Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells.
Zhang Y; Chang S; Sun J; Zhu S; Pu C; Li Y; Zhu Y; Wang Z; Xu RX
Mol Pharm; 2015 Sep; 12(9):3137-45. PubMed ID: 26212628
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
[TBL] [Abstract][Full Text] [Related]
15. KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.
Dong Z; Yang L; Lai D
Cell Prolif; 2013 Aug; 46(4):425-35. PubMed ID: 23869764
[TBL] [Abstract][Full Text] [Related]
16. Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling.
Huang K; Li LA; Meng YG; You YQ; Fu XY; Song L
Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):507-11. PubMed ID: 24842412
[TBL] [Abstract][Full Text] [Related]
17. Survivin Promotes Piperlongumine Resistance in Ovarian Cancer.
Nan XW; Gong LH; Chen X; Zhou HH; Ye PP; Yang Y; Xing ZH; Wei MN; Li Y; Wang ST; Liu K; Shi Z; Yan XJ
Front Oncol; 2019; 9():1345. PubMed ID: 31850227
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
[TBL] [Abstract][Full Text] [Related]
19. [Expression of survivin in ovarian epithelial carcinoma and its correlation with expression of Fas and FasL].
Ma XY; He FX; Wu SF; Lu YP; Ma D
Ai Zheng; 2004 Feb; 23(2):173-6. PubMed ID: 14960238
[TBL] [Abstract][Full Text] [Related]
20. Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.
Liu X; Chong Y; Liu H; Han Y; Niu M
J Ovarian Res; 2015 Jun; 8():35. PubMed ID: 26055813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]